Pyrrolidone carboxylic acid → HCID 24767925, compound
Reaction equation
[O:1]=[C:2]([CH2:4][N:5]([C:7](=[NH:9])[NH2:8])[CH3:6])[OH:3].[NH:10]1[C:14](=[O:15])[CH2:13][CH2:12][CH:11]1[C:16]([OH:18])=[O:17].C(O)C>C(OCC)(=O)C>[NH:10]1[C:14](=[O:15])[CH2:13][CH2:12][C@H:11]1[C:16]([OH:18])=[O:17].[O:1]=[C:2]([CH2:4][N:5]([C:7](=[NH:8])[NH2:9])[CH3:6])[OH:3]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
According to a preferred embodiment, the aforementioned salt can be prepared by reacting creatine with an equimolar amount of D,L-pyroglutamic acid in ethyl acetate (or in a mixture of equal parts ethyl acetate and ethanol) until complete formation of the salt. The solution can be optionally concentrated and, upon cooling, the crystallized salts are filtered and washed with ethyl acetate (or a mixture of ethyl acetate and ethanol). Alternatively, the procedure can be carried on by reacting excess D,L-pyroglutamic acid with creatine in ethyl acetate (or a mixture of ethyl acetate and ethanol).
Workup
- customthe aforementioned salt can be prepared
- concentrationThe solution can be optionally concentrated
- temperatureupon cooling
- filtrationthe crystallized salts are filtered
- washwashed with ethyl acetate (or
- additiona mixture of ethyl acetate and ethanol)
- additiona mixture of ethyl acetate and ethanol)
Sources & evidence
- ORD record
- ord-9fc5556682ce4801bcee4f87ad68571f
- Source dataset
- uspto-grants-2008_12
- Patent number
- US07465812B2
Reaction notes
Loading…